$ECYT Headlines Six charts to watch for upside m
Post# of 102254
Posted On: 12/12/2013 10:24:19 AM
$ECYT Headlines
Six charts to watch for upside moves 12:33 p.m. March 28, 2013 - The Trading Deck
J&J to supply additional Doxil for clinical trials 11:16 a.m. Aug. 2, 2012 - MarketWatch.com
Endocyte shares extend gains in after-hours trade 4:50 p.m. April 16, 2012 - Carla Mozee
Stocks to watch Tuesday: Coke, Goldman Sachs 4:32 p.m. April 16, 2012 - David B. Wilkerson
Monday’s biggest gaining and declining stocks 1:34 p.m. April 16, 2012 - MarketWatch
Endocyte soars 101% on Merck deal 10:43 a.m. April 16, 2012 - Val Brickates Kennedy
Merck to pay Endocyte up to $1 bln for cancer drug 6:57 a.m. April 16, 2012 - MarketWatch.com
Endocyte rockets 60% on EU update 12:09 p.m. March 14, 2012 - Val Brickates Kennedy
Endocyte plunges on drug study results 11:48 a.m. Dec. 13, 2011 - Val Brickates Kennedy
LinkedIn's surge sparks valuation questions 1:28 p.m. May 19, 2011 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 4:00 p.m. April 26, 2011 - Kate Gibson
UPDATE: Piper Jaffray Initiates Coverage on Endocyte on Multiple Drivers at Attractive Valuation 8:00 a.m. Dec. 2, 2013 - benzinga.com
Benzinga's Top Initiations 7:32 a.m. Dec. 2, 2013 - benzinga.com
10-Q: ENDOCYTE INC 4:48 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Narrower-than-Expected Loss at Endocyte - Analyst Blog 10:50 a.m. Nov. 6, 2013 - Zacks.com
Endocyte's CEO Discusses Q3 2013 Results - Earnings Call Transcript 10:54 p.m. Nov. 5, 2013 - Seeking Alpha
Endocyte's Plunge Ignores Drug's $2.5B Potential 1:47 p.m. Oct. 30, 2013 - Seeking Alpha
ECYT's Shares Rise on Positive Phase II Data - Analyst Blog 5:23 p.m. Oct. 16, 2013 - Zacks.com
Endocyte's Pipeline Encourages - Analyst Blog 3:35 p.m. Oct. 15, 2013 - Zacks.com
Endocyte Receives DSMB Recommendation for Continuation of Vintafolid/Docetaxel Combo 5:47 a.m. Oct. 11, 2013 - benzinga.com
2 Are Better Than 1: Endocyte Uses Diagnostics To Complements Its Drugs 11:09 a.m. Sept. 29, 2013 - Seeking Alpha
Leaning Towards Favorable Outcomes From Endocyte's Upcoming Events 9:32 a.m. Sept. 12, 2013 - Seeking Alpha
Endocyte - Nihon Medi-Physics Collaborate - Analyst Blog 3:30 p.m. Sept. 6, 2013 - Zacks.com
Endocyte and Nihon Medi-Physics (NMP) Enter Into Exclusive License Agreement to Develop and Commercialize Companion Imaging Diagnostic Etarfolatide for Cancer in Japan 2:10 p.m. Sept. 5, 2013 - benzinga.com
10-Q: ENDOCYTE INC 1:06 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Wedbush Expert Declares Money For Biotech Is Still Out There 10:47 a.m. Aug. 9, 2013 - Seeking Alpha
Wider Than Expected Losses At Endocyte May Not Mean A Pullback 2:11 a.m. Aug. 7, 2013 - Seeking Alpha
Wider-than-Expected Loss at Endocyte - Analyst Blog 4:00 p.m. Aug. 2, 2013 - Zacks.com
Endocyte's CEO Discusses Q2 2013 Results - Earnings Call Transcript 11:27 a.m. Aug. 2, 2013 - Seeking Alpha
Meet High Risk And High Reward, Biotech's Profit Partners: Bert Hazlett 10:03 a.m. July 26, 2013 - Seeking Alpha
Endocyte One-Two Punch Aims At Ovarian Cancer 2:50 p.m. July 24, 2013 - Investors Business Daily
Endocyte to Present at the Piper Jaffray 25th Annual Health Care Conference 4:01 p.m. Nov. 26, 2013 - GlobeNewswire
Biotech Companies Announce Upcoming Conferences, Appointments - Research Report on Illumina, Epizyme, Questcor Pharmaceuticals, Infinity, and Endocyte 8:00 a.m. Nov. 19, 2013 - PR Newswire
Colin Goddard, Ph.D., Joins the Endocyte Board of Directors 4:02 p.m. Nov. 7, 2013 - GlobeNewswire
Endocyte to Present at the 2013 Credit Suisse Healthcare Conference 4:01 p.m. Nov. 6, 2013 - GlobeNewswire
Endocyte Reports Third Quarter 2013 Financial Results and Provides Business Update 4:02 p.m. Nov. 5, 2013 - GlobeNewswire
Endocyte Announces Third Quarter 2013 Earnings Conference Call 3:02 p.m. Oct. 23, 2013 - GlobeNewswire
Successful Launches, Upcoming Conference Calls, Signing of Agreements, and Trial Results - Research Report on Vertex, Illumina, Alexion, VIVUS, and Endocyte 7:00 a.m. Oct. 16, 2013 - PR Newswire
Results of Phase II PRECEDENT Trial for Investigational Folate Receptor Therapy Vintafolide in Patients with Platinum-Resistant Ovarian Cancer Published in Journal of Clinical Oncology 4:02 p.m. Oct. 14, 2013 - BusinessWire
Endocyte Announces DSMB Recommendation for Continuation of Vintafolide/Docetaxel Combination and Docetaxel Monotherapy Arms of the Phase 2b TARGET Trial in Non-Small Cell Lung Cancer 6:45 a.m. Oct. 11, 2013 - GlobeNewswire
Endocyte Announces Presentations at the 246th American Chemical Society Meeting & Exposition 3:01 p.m. Sept. 9, 2013 - GlobeNewswire
Endocyte and Nihon Medi-Physics (NMP) Enter Into Exclusive License Agreement to Develop and Commercialize Companion Imaging Diagnostic Etarfolatide for Cancer in Japan 3:01 p.m. Sept. 5, 2013 - GlobeNewswire
Endocyte to Present at Upcoming Conferences in September 3:01 p.m. Aug. 27, 2013 - GlobeNewswire
Endocyte to Present at the Wedbush 2013 Life Sciences Management Access Conference 3:40 p.m. Aug. 6, 2013 - GlobeNewswire
Endocyte Announces Second Quarter 2013 Earnings Conference Call 3:01 p.m. July 18, 2013 - GlobeNewswire
Endocyte Announces Poster Presentations on Vintafolide and Etarfolatide at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO) 3:01 p.m. May 30, 2013 - GlobeNewswire
Endocyte to Present at the Jefferies 2013 Global Healthcare Conference 3:01 p.m. May 29, 2013 - GlobeNewswire
Endocyte Appoints Scot L. Harper, Ph.D., as Vice President of Clinical Operations 3:01 p.m. May 7, 2013 - GlobeNewswire
Endocyte Reports First Quarter 2013 Financial Results and Business Update 3:01 p.m. May 2, 2013 - GlobeNewswire
Clinical Study Shows Involvement of Activated Macrophages in Osteoarthritis, Identified by Endocyte's Etarfolatide 4:14 p.m. April 25, 2013 - GlobeNewswire
Endocyte, Inc. Announces Annual Stockholders' Meeting 3:01 p.m. April 22, 2013 - GlobeNewswire
Six charts to watch for upside moves 12:33 p.m. March 28, 2013 - The Trading Deck
J&J to supply additional Doxil for clinical trials 11:16 a.m. Aug. 2, 2012 - MarketWatch.com
Endocyte shares extend gains in after-hours trade 4:50 p.m. April 16, 2012 - Carla Mozee
Stocks to watch Tuesday: Coke, Goldman Sachs 4:32 p.m. April 16, 2012 - David B. Wilkerson
Monday’s biggest gaining and declining stocks 1:34 p.m. April 16, 2012 - MarketWatch
Endocyte soars 101% on Merck deal 10:43 a.m. April 16, 2012 - Val Brickates Kennedy
Merck to pay Endocyte up to $1 bln for cancer drug 6:57 a.m. April 16, 2012 - MarketWatch.com
Endocyte rockets 60% on EU update 12:09 p.m. March 14, 2012 - Val Brickates Kennedy
Endocyte plunges on drug study results 11:48 a.m. Dec. 13, 2011 - Val Brickates Kennedy
LinkedIn's surge sparks valuation questions 1:28 p.m. May 19, 2011 - MarketWatch.com
Tuesday’s biggest gaining and declining stocks 4:00 p.m. April 26, 2011 - Kate Gibson
UPDATE: Piper Jaffray Initiates Coverage on Endocyte on Multiple Drivers at Attractive Valuation 8:00 a.m. Dec. 2, 2013 - benzinga.com
Benzinga's Top Initiations 7:32 a.m. Dec. 2, 2013 - benzinga.com
10-Q: ENDOCYTE INC 4:48 p.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Narrower-than-Expected Loss at Endocyte - Analyst Blog 10:50 a.m. Nov. 6, 2013 - Zacks.com
Endocyte's CEO Discusses Q3 2013 Results - Earnings Call Transcript 10:54 p.m. Nov. 5, 2013 - Seeking Alpha
Endocyte's Plunge Ignores Drug's $2.5B Potential 1:47 p.m. Oct. 30, 2013 - Seeking Alpha
ECYT's Shares Rise on Positive Phase II Data - Analyst Blog 5:23 p.m. Oct. 16, 2013 - Zacks.com
Endocyte's Pipeline Encourages - Analyst Blog 3:35 p.m. Oct. 15, 2013 - Zacks.com
Endocyte Receives DSMB Recommendation for Continuation of Vintafolid/Docetaxel Combo 5:47 a.m. Oct. 11, 2013 - benzinga.com
2 Are Better Than 1: Endocyte Uses Diagnostics To Complements Its Drugs 11:09 a.m. Sept. 29, 2013 - Seeking Alpha
Leaning Towards Favorable Outcomes From Endocyte's Upcoming Events 9:32 a.m. Sept. 12, 2013 - Seeking Alpha
Endocyte - Nihon Medi-Physics Collaborate - Analyst Blog 3:30 p.m. Sept. 6, 2013 - Zacks.com
Endocyte and Nihon Medi-Physics (NMP) Enter Into Exclusive License Agreement to Develop and Commercialize Companion Imaging Diagnostic Etarfolatide for Cancer in Japan 2:10 p.m. Sept. 5, 2013 - benzinga.com
10-Q: ENDOCYTE INC 1:06 p.m. Aug. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Wedbush Expert Declares Money For Biotech Is Still Out There 10:47 a.m. Aug. 9, 2013 - Seeking Alpha
Wider Than Expected Losses At Endocyte May Not Mean A Pullback 2:11 a.m. Aug. 7, 2013 - Seeking Alpha
Wider-than-Expected Loss at Endocyte - Analyst Blog 4:00 p.m. Aug. 2, 2013 - Zacks.com
Endocyte's CEO Discusses Q2 2013 Results - Earnings Call Transcript 11:27 a.m. Aug. 2, 2013 - Seeking Alpha
Meet High Risk And High Reward, Biotech's Profit Partners: Bert Hazlett 10:03 a.m. July 26, 2013 - Seeking Alpha
Endocyte One-Two Punch Aims At Ovarian Cancer 2:50 p.m. July 24, 2013 - Investors Business Daily
Endocyte to Present at the Piper Jaffray 25th Annual Health Care Conference 4:01 p.m. Nov. 26, 2013 - GlobeNewswire
Biotech Companies Announce Upcoming Conferences, Appointments - Research Report on Illumina, Epizyme, Questcor Pharmaceuticals, Infinity, and Endocyte 8:00 a.m. Nov. 19, 2013 - PR Newswire
Colin Goddard, Ph.D., Joins the Endocyte Board of Directors 4:02 p.m. Nov. 7, 2013 - GlobeNewswire
Endocyte to Present at the 2013 Credit Suisse Healthcare Conference 4:01 p.m. Nov. 6, 2013 - GlobeNewswire
Endocyte Reports Third Quarter 2013 Financial Results and Provides Business Update 4:02 p.m. Nov. 5, 2013 - GlobeNewswire
Endocyte Announces Third Quarter 2013 Earnings Conference Call 3:02 p.m. Oct. 23, 2013 - GlobeNewswire
Successful Launches, Upcoming Conference Calls, Signing of Agreements, and Trial Results - Research Report on Vertex, Illumina, Alexion, VIVUS, and Endocyte 7:00 a.m. Oct. 16, 2013 - PR Newswire
Results of Phase II PRECEDENT Trial for Investigational Folate Receptor Therapy Vintafolide in Patients with Platinum-Resistant Ovarian Cancer Published in Journal of Clinical Oncology 4:02 p.m. Oct. 14, 2013 - BusinessWire
Endocyte Announces DSMB Recommendation for Continuation of Vintafolide/Docetaxel Combination and Docetaxel Monotherapy Arms of the Phase 2b TARGET Trial in Non-Small Cell Lung Cancer 6:45 a.m. Oct. 11, 2013 - GlobeNewswire
Endocyte Announces Presentations at the 246th American Chemical Society Meeting & Exposition 3:01 p.m. Sept. 9, 2013 - GlobeNewswire
Endocyte and Nihon Medi-Physics (NMP) Enter Into Exclusive License Agreement to Develop and Commercialize Companion Imaging Diagnostic Etarfolatide for Cancer in Japan 3:01 p.m. Sept. 5, 2013 - GlobeNewswire
Endocyte to Present at Upcoming Conferences in September 3:01 p.m. Aug. 27, 2013 - GlobeNewswire
Endocyte to Present at the Wedbush 2013 Life Sciences Management Access Conference 3:40 p.m. Aug. 6, 2013 - GlobeNewswire
Endocyte Announces Second Quarter 2013 Earnings Conference Call 3:01 p.m. July 18, 2013 - GlobeNewswire
Endocyte Announces Poster Presentations on Vintafolide and Etarfolatide at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO) 3:01 p.m. May 30, 2013 - GlobeNewswire
Endocyte to Present at the Jefferies 2013 Global Healthcare Conference 3:01 p.m. May 29, 2013 - GlobeNewswire
Endocyte Appoints Scot L. Harper, Ph.D., as Vice President of Clinical Operations 3:01 p.m. May 7, 2013 - GlobeNewswire
Endocyte Reports First Quarter 2013 Financial Results and Business Update 3:01 p.m. May 2, 2013 - GlobeNewswire
Clinical Study Shows Involvement of Activated Macrophages in Osteoarthritis, Identified by Endocyte's Etarfolatide 4:14 p.m. April 25, 2013 - GlobeNewswire
Endocyte, Inc. Announces Annual Stockholders' Meeting 3:01 p.m. April 22, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼